The Australian Institute for Bioengineering and Nanotechnology (AIBN) invites you to meet our newest Group Leader, Dr Ruirui Qiao. 

AIBN creates practical solutions in health, energy and the bioeconomy, through research in Precision Nanomedicine, Advanced Biomanufacturing and Advanced Nano-Materials. Join us as Dr Qiao shares her research focus and ask questions to further understand her research and where there may be opportunities for collaboration. 

The seminar will cover the design and fabrication of different types of functional polymeric/inorganic nanohybrids as imaging probes for diagnosis of diseases. 


Hybrid nanomaterials, with an inorganic core and organic surface coating, has shown great potential in a number of fields such as health, environment, microfluidics, as well as imaging and targeting delivery. Instead of utilising solely functions from either metal-based inorganic materials (e.g. Iron oxides, upconversion nanoparticles (UCNPs), Au nanoparticles, quantum dots, liquid metal nanoparticles (LMNPs), etc.) or organic polymers with unique properties (e.g. biocompatibility, chemical or biochemical reactivity, optical or electrical characteristics), hybrid functional materials involve a synergic combination of two chemical worlds to generate new materials with improved performance or even novel properties. In bioapplications such as imaging or targeting delivery, the advantages of hybrid nanoparticle-based imaging agents include tailorable size and surface, high loading capacity, controllable or environmental responsive signal activation, reduced side effect and improved biocompatibility.

3 things people will learn by coming to this seminar:

  • The fabrication strategies of polymer and inorganic nanoparticles
  • The functionalisation with biomolecules for targeting
  • The applications and performance of nanohybrids as imaging probes
About Dr Qiao

Dr. Ruirui Qiao is a Group leader and NHMRC Emerging Leadership fellow at Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland. She received her BSc (2005) and MSc (2007) in pharmaceutical science in Peking University in China. From 2007 to 2016, she worked as a research assistant and associate in Institute of Chemistry, Chinese Academy of Science (CAS). In 2016, she was promoted to be an associated Professor in Chinese Academy of Sciences. In 2017, she joined Monash Institute of Pharmaceutical Sciences (MIPS) as a research fellow within ARC Centre of Bio-Nano Science (CBNS) under the leadership and mentorship of Professor Tom Davis. In 2019, she relocated to AIBN as the co-project leader of CBNS. Her research focuses on the development of polymeric/inorganic nanohybrids and assemblies for disease diagnosis and therapy. 

Who should attend

  • Anyone with an interest in polymer and inorganic nanoparticles or collaborating with AIBN
  • UQ Researchers, including Students, Early and Mid-Career Researchers, Group Leaders and Chief Investigators
  • Businesses and Organisations working in polymer and inorganic nanoparticles
  • State and Federal Government representatives interested in polymer and inorganic nanoparticles


This event is being delivered online.

Please register to receive your online access link.